Antisaccades in Parkinson's Disease: A Meta-Analysis
Josefine Waldthaler1,2, Lena Stock3, Justus Student3
1Department of Neurology, University Hospital Marburg, 35033, Marburg, Germany. josefine.waldthaler@staff.uni-marburg.de.
Neuropsychology Review
|March 20, 2021
Summary
Eye-tracking tests, specifically the antisaccade task, show altered performance in Parkinson's disease (PD). Increased antisaccade latency and error rates in PD correlate with disease severity, suggesting potential as a biomarker.
Area of Science:
- Neuroscience
- Ophthalmology
- Neurology
Background:
- Eye-tracking tasks are explored as potential biomarkers for Parkinson's disease (PD).
- Previous research suggests altered antisaccade task performance in PD, linked to motor and executive dysfunction.
Purpose of the Study:
- To synthesize evidence on antisaccade error rates and latency in PD through meta-analysis.
- To investigate the influence of disease severity, medication, and deep brain stimulation on antisaccade performance.
Main Methods:
- Random effects models were employed for meta-analysis of antisaccade data in PD.
- Meta-regressions assessed correlations with motor/cognitive severity, medication, and study factors.
- Sub-analyses examined acute levodopa and deep brain stimulation effects.
Main Results:
- Antisaccade latency and error rates are significantly elevated in Parkinson's disease patients.
- Disease duration, UPDRS score, and Hoehn and Yahr stage correlate with increased antisaccade latency.
- Acute levodopa showed no significant effect; deep brain stimulation may increase impulsivity.
Conclusions:
- Antisaccade performance is impaired in PD and linked to motor burden.
- Antisaccade latency shows potential as a biomarker for PD severity and progression.
- Further longitudinal studies are needed to confirm these findings.
Related Concept Videos
Parkinson's Disease: Treatment
713
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
713
Parkinson's Disease: Overview
1.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.1K


